This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kohno, T. Articles by Ozawa, K. Search for Related Content PubMed PubMed Citation Articles by Kohno, T. Articles by Ozawa, K.

Interleukin-10-mediated Inhibition of Angiogenesis and Tumor Growth in Mice Bearing VEGF-producing Ovarian Cancer¹

Division of Genetic Therapeutics, Center for Molecular Medicine [T. K., H. M., Y. S., Y. T., M. S., T. M., T. O., Y. H., A. K., K. O.] and Department of Obstetrics and Gynecology [M. S., Y. S., Y. T., I. S.], Jichi Medical School, Tochigi, 329-0498 Japan

Interleukin-10 (IL-10) is an immunosuppressive cytokine produced by T lymphocytes and drawing attention as an inhibitor of tumor angiogenesis. In this study, we investigated antiangiogenic and tumor suppressive effects of IL-10 in ovarian cancer cells. mIL-10-expressing plasmid was transferred into two ovarian cancer cell lines, SHIN-3 [vascular endothelial growth factor (VEGF) producing] and KOC-2S (non-VEGF producing). After selection, mIL-10-expressing cells were obtained as SHIN-3/mIL-10 and KOC-2S/mIL-10. No significant differences were observed in in vitro growth properties between mIL-10-expressing cells and control (luciferase expressing) cells in either KOC-2S or SHIN-3. The angiogenic activities of mIL-10-expressing cells were measured by dorsal air sac assay, which detected the number of newly formed blood vessels within a chamber in vivo. In addition, tumor formation was evaluated by s.c. tumor transplantation, and survival was monitored after i.p. injection of ovarian cancer cells into BALB/c nude mice. Both in vivo angiogenic activity and tumor growth were significantly inhibited in SHIN-3/mIL-10 cells compared with the control. Moreover, peritoneal dissemination was inhibited, and the survival period was significantly prolonged (mean survival days > 90 versus 36). In contrast, in the case of KOC-2S cells, no significant differences were observed in any of the parameters tested. These results indicate that IL-10 has suppressive effects on angiogenesis, tumor growth, and peritoneal dissemination of VEGF-producing ovarian cancer cells. Although the mechanisms of the antiangiogenic effect of IL-10 are still unclear, the potential usefulness of IL-10-mediated gene therapy of ovarian cancer was suggested.

This article has been cited by other articles:

				S V Goverdhan, S Ennis, S R Hannan, K C Madhusudhana, A J Cree, A J Luff, and A J Lotery Interleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration Br. J. Ophthalmol., April 1, 2008; 92(4): 537 - 540. [Abstract] [Full Text] [PDF]

				Y. Takei, Y. Saga, H. Mizukami, T. Takayama, M. Ohwada, K. Ozawa, and M. Suzuki Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice Mol. Cancer Ther., March 1, 2008; 7(3): 704 - 711. [Abstract] [Full Text] [PDF]

				P. Zamiri, S. Masli, J. W. Streilein, and A. W. Taylor Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3912 - 3918. [Abstract] [Full Text] [PDF]